SQZ(Delisted)
Sqz BiotechnologiesยทNYSE
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SQZ
Sqz Biotechnologies Company
A biotech company that develops transformative cell therapies to treat cancer, infetious diseases with its cell squeeze technology
200 Arsenal Yards Blvd, Suite 210, Watertown, MA 02472
--
Sqz Biotechnologies Company was incorporated in March 2013 under the laws of the State of Delaware. The company is a clinical-stage biotechnology company that develops translational cell therapies for patients with cancer, infectious diseases and other serious diseases.
Company Financials
EPS
SQZ has released its 2023 Q2 earnings. EPS was reported at -0.8, versus the expected 0, missing expectations. The chart below visualizes how SQZ has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
